Monte Carlo GEANT4-based application for in vivo RBE study using small animals at LNS-INFN preclinical hadrontherapy facility

Autor: P. Pisciotta a, b, c, F.P. Cammarata c, A. Stefano c, F. Romano d, V. Marchese a, F. Torrisi e, G.I. Forte c, L. Cella f, g, G.A.P. Cirrone b, G. Petringa b, M.C. Gilardi c, G. Cuttone b, G. Russo b

Publikováno v: Physica medica (Testo stamp.) 54 (2018): 173–178. doi:10.1016/j.ejmp.2018.07.003
info:cnr-pdr/source/autori:P. Pisciotta a,b,c, F.P. Cammarata c, A. Stefano c, F. Romano d,b, V. Marchese a,c, F. Torrisi e, G.I. Forte c, L. Cella f,g, G.A.P. Cirrone b, G. Petringa b, M.C. Gilardi c, G. Cuttone b, G. Russo b,c/titolo:Monte Carlo GEANT4-based application for in vivo RBE study using small animals at LNS-INFN preclinical hadrontherapy facility/doi:10.1016%2Fj.ejmp.2018.07.003/rivista:Physica medica (Testo stamp.)/anno:2018/pagina_da:173/pagina_a:178/intervallo_pagine:173–178/volume:54

Preclinical studies represent an important step towards a deep understanding of the biological response to ionizing radiations. The effectiveness of proton therapy is higher than photons and, for clinical purposes, a fixed value of 1.1 is used for th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ddc2f09cbc96c578ed287504732e3c
https://doi.org/10.1016/j.ejmp.2018.07.003